BIOMAT Database Logo BIOMAT Database Logo

Synthesis of CPT-11 (irinotecan hydrochloride trihydrate). 1996

S Sawada, and T Yokokura, and T Miyasaka
Yakult Central Institute for Microbiological Research, Tokyo, Japan.

UI MeSH Term Description Entries
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D000077146 Irinotecan A semisynthetic camptothecin derivative that inhibits DNA TOPOISOMERASE I to prevent nucleic acid synthesis during S PHASE. It is used as an antineoplastic agent for the treatment of COLORECTAL NEOPLASMS and PANCREATIC NEOPLASMS. 7-Ethyl-10-hydroxycamptothecin,CPT 11,CPT-11,Camptosar,Camptothecin-11,Irinotecan Hydrochloride,Irrinotecan,NK012 Compound,SN 38,SN 38 11,SN-38,SN-38-11,7 Ethyl 10 hydroxycamptothecin,CPT11,Camptothecin 11,SN3811
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics

Related Publications

S Sawada, and T Yokokura, and T Miyasaka
[Irinotecan hydrochloride (CPT-11)].
April 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
S Sawada, and T Yokokura, and T Miyasaka
[Irinotecan hydrochloride (CPT-11) for advanced cervical cancer].
October 2004, Nihon rinsho. Japanese journal of clinical medicine,
S Sawada, and T Yokokura, and T Miyasaka
[CPT-11 (Irinotecan)].
February 2008, Gan to kagaku ryoho. Cancer & chemotherapy,
S Sawada, and T Yokokura, and T Miyasaka
Irinotecan hydrochloride (CPT-11) in dialysis patients with gastrointestinal cancer.
February 2010, Acta medica Okayama,
S Sawada, and T Yokokura, and T Miyasaka
[Phase I study with irinotecan hydrochloride (CPT-11) for advanced neuroblastoma].
December 2001, Gan to kagaku ryoho. Cancer & chemotherapy,
S Sawada, and T Yokokura, and T Miyasaka
Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy.
October 1994, British journal of cancer,
S Sawada, and T Yokokura, and T Miyasaka
[Late phase II study of irinotecan hydrochloride (CPT-11) in advanced gastric cancer. CPT-11 Gastrointestinal Cancer Study Group].
June 1994, Gan to kagaku ryoho. Cancer & chemotherapy,
S Sawada, and T Yokokura, and T Miyasaka
Clinical pharmacogenetics of irinotecan (CPT-11).
January 2005, Drug metabolism reviews,
S Sawada, and T Yokokura, and T Miyasaka
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
October 2006, Cancer chemotherapy and pharmacology,
S Sawada, and T Yokokura, and T Miyasaka
Irinotecan (CPT-11): a brief overview.
January 1996, Clinical and experimental pharmacology & physiology,
Copied contents to your clipboard!